Source: Pharmacy Times articles
Compared with placebo, patients with cholestatic pruritus and primary biliary cholangitis (PBC) receiving linerixibat experienced improved itch and sleep interference.
Read More
by MM360 Staff | May 20, 2025 | Myeloma News | 0 comments
Source: Pharmacy Times articles
Compared with placebo, patients with cholestatic pruritus and primary biliary cholangitis (PBC) receiving linerixibat experienced improved itch and sleep interference.
Read More